A recent breakthrough in China shows promise for reversing Type 1 and Type 2 diabetes using patient-derived stem cells to regenerate insulin-producing beta cells. The therapy, avoiding immune rejection, has shown successful outcomes, eliminating the need for insulin. However, significant obstacles like pharmaceutical resistance and limited access remain before widespread adoption.
Stem Cell Breakthrough in China: A New Hope for Reversing Diabetes
Posted on